Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein
Reducing the mortality and morbidity associated with COVID-19 remains a global health priority. Vaccines have proven highly effective at preventing infection and hospitalization, but efforts must continue to improve treatment options for those who still become seriously ill.
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2021-08-01
|
| Series: | mSphere |
| Online Access: | https://journals.asm.org/doi/10.1128/mSphere.00647-21 |
| id |
doaj-614e579dc1434819ab00e4dbdcf745a2 |
|---|---|
| record_format |
Article |
| spelling |
doaj-614e579dc1434819ab00e4dbdcf745a22021-09-21T19:41:35ZengAmerican Society for MicrobiologymSphere2379-50422021-08-016410.1128/mSphere.00647-21Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike GlycoproteinRobert J. Ragotte0https://orcid.org/0000-0002-6463-1595David Pulido1Francesca R. Donnellan2Michelle L. Hill3Giacomo Gorini4Hannah Davies5Juliane Brun6Kirsty McHugh7Lloyd D. W. King8Katherine Skinner9Kazutoyo Miura10Carole A. Long11Nicole Zitzmann12Simon J. Draper13Jenner Institute, University of Oxford, Oxford, United KingdomJenner Institute, University of Oxford, Oxford, United KingdomJenner Institute, University of Oxford, Oxford, United KingdomOxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, United KingdomJenner Institute, University of Oxford, Oxford, United KingdomJenner Institute, University of Oxford, Oxford, United KingdomOxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, United KingdomJenner Institute, University of Oxford, Oxford, United KingdomJenner Institute, University of Oxford, Oxford, United KingdomJenner Institute, University of Oxford, Oxford, United KingdomLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USALaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USAOxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, United KingdomJenner Institute, University of Oxford, Oxford, United Kingdom Reducing the mortality and morbidity associated with COVID-19 remains a global health priority. Vaccines have proven highly effective at preventing infection and hospitalization, but efforts must continue to improve treatment options for those who still become seriously ill.https://journals.asm.org/doi/10.1128/mSphere.00647-21 |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Robert J. Ragotte David Pulido Francesca R. Donnellan Michelle L. Hill Giacomo Gorini Hannah Davies Juliane Brun Kirsty McHugh Lloyd D. W. King Katherine Skinner Kazutoyo Miura Carole A. Long Nicole Zitzmann Simon J. Draper |
| spellingShingle |
Robert J. Ragotte David Pulido Francesca R. Donnellan Michelle L. Hill Giacomo Gorini Hannah Davies Juliane Brun Kirsty McHugh Lloyd D. W. King Katherine Skinner Kazutoyo Miura Carole A. Long Nicole Zitzmann Simon J. Draper Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein mSphere |
| author_facet |
Robert J. Ragotte David Pulido Francesca R. Donnellan Michelle L. Hill Giacomo Gorini Hannah Davies Juliane Brun Kirsty McHugh Lloyd D. W. King Katherine Skinner Kazutoyo Miura Carole A. Long Nicole Zitzmann Simon J. Draper |
| author_sort |
Robert J. Ragotte |
| title |
Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein |
| title_short |
Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein |
| title_full |
Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein |
| title_fullStr |
Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein |
| title_full_unstemmed |
Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein |
| title_sort |
human basigin (cd147) does not directly interact with sars-cov-2 spike glycoprotein |
| publisher |
American Society for Microbiology |
| series |
mSphere |
| issn |
2379-5042 |
| publishDate |
2021-08-01 |
| description |
Reducing the mortality and morbidity associated with COVID-19 remains a global health priority. Vaccines have proven highly effective at preventing infection and hospitalization, but efforts must continue to improve treatment options for those who still become seriously ill. |
| url |
https://journals.asm.org/doi/10.1128/mSphere.00647-21 |
| work_keys_str_mv |
AT robertjragotte humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT davidpulido humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT francescardonnellan humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT michellelhill humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT giacomogorini humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT hannahdavies humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT julianebrun humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT kirstymchugh humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT lloyddwking humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT katherineskinner humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT kazutoyomiura humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT carolealong humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT nicolezitzmann humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT simonjdraper humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein |
| _version_ |
1717372186170228736 |